Are you Dr. Takahashi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
15700 Sw Greystone Court
Beaverton, OR 97006Phone+1 503-203-1000Fax+1 503-203-1010
Summary
- Dr. Gary Takahashi, MD is an oncologist in Beaverton, Oregon. He is currently licensed to practice medicine in Oregon and Washington. He is affiliated with Providence St. Vincent Medical Center, OHSU Hospital, and Legacy Meridian Park Medical Center.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1988 - 1993
- Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterResidency, Internal Medicine, 1987 - 1988
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1984 - 1987
- University of Hawaii, John A. Burns School of MedicineClass of 1984
Certifications & Licensure
- OR State Medical License 1985 - 2025
- WA State Medical License 1988 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- Efficacy of Abemaciclib in the Management of Refractory Metastatic Extramammary Paget's Disease.Gary W Takahashi, John Vetto, Justin J Leitenberger, Arthur Hung
Cureus. 2022-07-01 - 11 citationsManagement of femoral fracture in a patient with essential thrombocythemia treated with plateletpheresis and intramedullary rod fixation, followed by hydroxyurea: a ca...Richard F. Edlich, William B. Long, Amy A. Cochran, Angela R. Kelley, Dayna R. Woode
The American Journal of Emergency Medicine. 2008-06-01 - 9 citationsNeoadjuvant chemoradiotherapy for esophageal cancer using weekly Paclitaxel and Carboplatin plus infusional 5-Fluorouracil.David E. Gannett, Ron F Wolf, Gary W Takahashi, Jeannie Louie, Rick C Wagner
Gastrointestinal Cancer Research. 2007-07-01
Professional Memberships
- Member